Agilent Technologies (NYSE:A) Price Target Raised to $180.00

Agilent Technologies (NYSE:A) had its target price boosted by TD Cowen from $155.00 to $180.00 in a research report report published on Thursday morning,Benzinga reports. TD Cowen currently has a buy rating on the medical research company’s stock.

A has been the subject of a number of other reports. Sanford C. Bernstein upped their price objective on shares of Agilent Technologies from $155.00 to $180.00 and gave the stock an “outperform” rating in a research report on Thursday. Wells Fargo & Company reduced their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research report on Thursday, May 28th. Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Sunday, August 2nd. Wolfe Research reiterated a “hold” rating on shares of Agilent Technologies in a research note on Tuesday, June 2nd. Finally, Robert W. Baird raised their target price on Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research report on Tuesday, May 26th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $170.33.

Agilent Technologies Stock Performance

Shares of A stock opened at $154.47 on Thursday. The company has a current ratio of 2.05, a quick ratio of 1.62 and a debt-to-equity ratio of 0.50. Agilent Technologies has a 12-month low of $108.35 and a 12-month high of $163.75. The business’s 50 day moving average is $140.30 and its two-hundred day moving average is $127.04. The company has a market capitalization of $43.63 billion, a P/E ratio of 30.41, a P/E/G ratio of 2.65 and a beta of 1.25.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, beating analysts’ consensus estimates of $1.49 by $0.13. The business had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.The business’s revenue was up 8.1% compared to the same quarter last year. During the same period in the previous year, the business earned $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Analysts expect that Agilent Technologies will post 6.2 EPS for the current fiscal year.

Hedge Funds Weigh In On Agilent Technologies

Several institutional investors and hedge funds have recently bought and sold shares of the company. Corient Private Wealth LP lifted its stake in shares of Agilent Technologies by 8.5% in the 2nd quarter. Corient Private Wealth LP now owns 240,532 shares of the medical research company’s stock valued at $31,952,000 after purchasing an additional 18,901 shares during the last quarter. Amundi lifted its stake in Agilent Technologies by 20.3% during the 2nd quarter. Amundi now owns 1,294,098 shares of the medical research company’s stock worth $171,891,000 after acquiring an additional 218,514 shares in the last quarter. HighTower Advisors LLC increased its stake in Agilent Technologies by 3.3% during the 2nd quarter. HighTower Advisors LLC now owns 176,828 shares of the medical research company’s stock worth $23,488,000 after buying an additional 5,710 shares during the period. California State Teachers Retirement System increased its holdings in Agilent Technologies by 12,343.3% during the 2nd quarter. California State Teachers Retirement System now owns 54,577,058 shares of the medical research company’s stock worth $7,249,471,000 after purchasing an additional 54,138,451 shares during the period. Finally, Wedmont Private Capital increased its position in shares of Agilent Technologies by 10.8% in the 2nd quarter. Wedmont Private Capital now owns 5,599 shares of the medical research company’s stock valued at $752,000 after purchasing an additional 547 shares during the last quarter.

Key Stories Impacting Agilent Technologies

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 earnings of $1.62 per share, above the $1.48-$1.49 analyst consensus, while revenue of approximately $1.88 billion also exceeded expectations. EPS increased from $1.37 a year earlier, supporting the view that profitability is improving. Agilent Technologies Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Management raised its full-year guidance following the strong quarter. Commentary highlighted product momentum, a recovery in China, improving demand and expanding margins, all of which could support additional earnings growth. Agilent Technologies Lifts Outlook After Strong Quarter
• Positive Sentiment: Several major firms raised their price targets and maintained bullish ratings after the results. Targets now range from $175 to $190, with upgrades from JPMorgan, Citi, Barclays, Goldman Sachs, Bank of America, Stifel, TD Cowen, Bernstein and RBC. Analysts Raise Agilent Technologies Price Targets
• Neutral Sentiment: Despite the improved outlook, valuation remains relatively demanding: Agilent trades at roughly 30 times earnings, with a PEG ratio above 2.7. This leaves the stock sensitive to any slowdown in demand or disappointment in future guidance.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.